| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 30.38B | 41.39B | 37.05B | 36.42B | 32.04B | 29.29B |
| Gross Profit | 6.52B | 9.40B | 8.91B | 7.99B | 6.63B | 6.41B |
| EBITDA | 3.67B | 6.58B | 6.60B | 5.53B | 4.30B | 3.94B |
| Net Income | 2.97B | 4.29B | 3.93B | 3.27B | 2.54B | 1.95B |
Balance Sheet | ||||||
| Total Assets | 50.43B | 51.34B | 48.57B | 49.17B | 44.30B | 36.65B |
| Cash, Cash Equivalents and Short-Term Investments | 8.97B | 9.52B | 10.67B | 12.19B | 10.56B | 7.28B |
| Total Debt | 5.71B | 5.38B | 5.09B | 8.03B | 8.97B | 7.05B |
| Total Liabilities | 24.61B | 26.43B | 25.82B | 27.29B | 25.66B | 21.00B |
| Stockholders Equity | 25.05B | 24.19B | 21.95B | 20.38B | 17.81B | 14.80B |
Cash Flow | ||||||
| Free Cash Flow | 2.04B | 848.95M | 1.97B | 1.97B | 1.14B | 2.08B |
| Operating Cash Flow | 3.22B | 2.40B | 3.94B | 3.06B | 2.26B | 2.96B |
| Investing Cash Flow | -795.24M | 904.87M | -634.54M | -1.31B | -3.53B | -1.56B |
| Financing Cash Flow | -309.40M | -2.90B | -4.78B | -946.63M | 1.63B | -877.39M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | HK$37.10B | 7.78 | 17.36% | 6.05% | 11.65% | 10.49% | |
65 Neutral | HK$45.26B | 12.26 | 12.26% | 1.39% | 11.26% | 15.82% | |
64 Neutral | HK$26.80B | 9.20 | 9.88% | 2.03% | -3.02% | 11.38% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | HK$13.13B | 13.41 | 4.88% | 1.02% | 7.11% | 65.26% | |
59 Neutral | HK$16.11B | 24.10 | 8.45% | 1.37% | 24.97% | 0.39% | |
58 Neutral | HK$36.69B | 50.06 | 6.21% | ― | 37.04% | ― |